News, infos and good to know WKN: A2QQ2E ISIN: US45256X1037 Kürzel: IBRX Forum: Aktien User: Lirumlarum1

Corona: Diese Universal-Impfstoffe werden gerade entwickelt: https://www.google.com/amp/s/www.morgenpost.de/vermischtes/article235123409/corona-impfung-universal-impfstoffe-varianten-forschung.html%3fservice=amp

Trademark Application of VESANKTIVA by ImmunityBio https://uspto.report/TM/97143778

ImmunityBio Provides Updated Status of Biologics License Application (BLA) for VesAnktiva Plus BCG for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-provides-updated-status-biologics-license?field_nir_news_date_value[min]=

Botswana Approves Corbevax Covid Vaccine, Plans Local Output Biotech billionaire Soon-Shiong speaks at launch in Botswana Soon-Shiong plans to build vaccine plant in the country https://www.bloomberg.com/news/articles/2022-03-28/botswana-approves-corbevax-covid-vaccine-plans-local-output

With big goals comes big growth! ImmunityBio grew by 243% last year when we merged with NantKwest. With our new facility in Dunkirk, the team will continue to grow. See our feature in @businessinsider's list of 17 fastest-growing drug companies of 2021: https://www.businessinsider.com/list-the-17-fastest-growing-biotechs-and-pharmas-of-2021-2022-3

Antikolonialer Akt Neue Einrichtung in Kapstadt soll Afrika bei der Impfstoffproduktion unabhängig vom Westen machen https://www.google.com/amp/s/www.nd-aktuell.de/amp/artikel/1160914.corona-in-afrika-antikolonialer-akt.amp.html

IMMUNITYBIO, INC. : Change in Directors or Principal Officers (form 8-K) www.marketscreener.com/amp/quote/stock/IMMUNITYBIO-INC-23160241/news/IMMUNITYBIO-INC-Change-in-Directors-or-Principal-Officers-form-8-K-39867223/

Auch GEO erwähnt ImmunityBio: Covid-Impfung 2.0: Wissenschaft arbeitet an neuen Universal-Impfstoffen www.geo.de/amp/wissen/gesundheit/corona-universal-impfstoffe-werden-erforscht-31709016.html

ImmunityBio: Extensive Pipeline, NDA Expected For Anktiva This Quarter https://www.google.com/amp/s/seekingalpha.com/amp/article/4495747-immunitybio-extensive-pipeline-nda-expected-for-anktiva-this-quarter

J.P. Morgan South Africa Healthcare Seminar MAR 15, 2022 Virtual J.P. Morgan is pleased to invite you to our annual South Africa Healthcare Seminar to be held virtually on March 15, 2022. https://ir.immunitybio.com/events/event-details/jp-morgan-south-africa-healthcare-seminar

PSS verknüpft AAHI (ehemals IDRI) mit seinen Tätigkeiten und wird in diesem gemeinnützigen Unternehmen Vorstandsvorsitzender. Unter Anderem läuft wohl dort dann auch Phase I/II des Covid-Impfstoffs: https://www.businesswire.com/news/home/20220302005470/en/

Memory Cytokine-Enhanced Natural Killer Cells Show Promising Results in Leukemia Patients; Data Support ImmunityBio’s Scaled m-ceNK Clinical Program https://ir.immunitybio.com/news-releases/news-release-details/memory-cytokine-enhanced-natural-killer-cells-show-promising?field_nir_news_date_value[min]=

This Post-Effective Amendment No. 1 contains: a base prospectus which covers the offering, issuance and sale by us of up to $330,795,982 in the aggregate of the securities identified above from time to time in one or more offerings; and  a sale agreement prospectus supplement covering the offering, issuance and sale by us of up to a maximum aggregate offering price of $330,795,982 of our common stock that may be issued and sold under a sale agreement with Jefferies LLC, or Jefferies. https://quantisnow.com/insight/2501489

The Worldwide Merkel Cell Carcinoma Disease Treatment Industry is Expected to Reach $3.7 Billion by 2026 https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/worldwide-merkel-cell-carcinoma-disease-120800044.html

Billionaire Soon-Shiong's firm lost 80% of its value in a year, but he has high hopes for SA plant https://www.google.com/amp/s/www.news24.com/amp/fin24/companies/billionaire-soon-shiongs-firm-lost-80-of-its-value-in-a-year-but-he-has-high-hopes-for-sa-plant-20220222